Make informed decisions. Try the FT.
Add this topic to your myFT Digest for news straight to your inbox
Vaping industry takes planned flavour restrictions in its stride
Regulators set to take tougher stance on flavoured cigarettes and vapes
Regulators are serious about a crackdown but any ban is likely to be some way off
US regulator to target tastes such as bubblegum to counter ‘epidemic’ teen use
Move comes as US drugs watchdog scrutinises spread of underage vaping
Regulators are in danger of doing more harm than good by curbing ecigarettes
US regulator sought items related to ecigarette maker’s ‘sales and marketing practices’
Nostrum CEO asked to explain 400% increase in antibiotic for bladder infections
Concerns raised on weak oversight in world’s largest producer of pharma ingredients
US FDA and EPA to assess new system for evaluating safety of chemicals
Failure to integrate an acquisition lay behind regulatory knock-back, says executive
Autonomous technology can make clinical decisions, allowing for convenient diagnosis
Anglo-Swedish group overcomes first step towards approval for new cancer medicines
Drugmakers eye sales gains at home on back of success in American market
Critics say regulation is needed but a voluntary approach may be more effective
Cost of two-in-one bottle surges even though drugs can be bought separately for $36
Consumers are left stranded when tracking apps and devices are switched off suddenly
Ann Aerts, drugmaker deal frenzy, India’s ‘menstrual man’
Luxturna is most expensive treatment on market and price raises affordability questions
DNA medicines justify a much higher price than conventional drugs
Spark Therapeutics gets green light in US for blindness treatment that could cost $1m
US opioid epidemic, change at UBS, Facebook tax, consumer debt and Apple buys Shazam
